Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $52.29
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price […]
More Stories
Bowlero Corp. (NYSE:BOWL) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Bowlero Corp. (NYSE:BOWL – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight...
dentalcorp Holdings Ltd. (TSE:DNTL) Receives Average Recommendation of “Buy” from Brokerages
dentalcorp Holdings Ltd. (TSE:DNTL – Get Free Report) has been given a consensus rating of “Buy” by the nine brokerages...
Wyndham Hotels & Resorts, Inc. (NYSE:WH) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Wyndham Hotels & Resorts, Inc. (NYSE:WH – Get Free Report) have been given an average recommendation of “Moderate...
Catalent, Inc. (NYSE:CTLT) Receives $58.08 Average PT from Brokerages
Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have earned an average recommendation of “Hold” from the seven analysts...
HP Inc. (NYSE:HPQ) Receives $35.55 Consensus PT from Analysts
Shares of HP Inc. (NYSE:HPQ – Get Free Report) have received an average recommendation of “Hold” from the twelve brokerages...
Salesforce, Inc. (NYSE:CRM) Receives $306.00 Consensus Target Price from Analysts
Salesforce, Inc. (NYSE:CRM – Get Free Report) has earned an average rating of “Moderate Buy” from the thirty-seven analysts that...